US EditionZimbabwe Rolls Out New HIV Prevention Drug Lenacapavir
Zimbabwe targets vulnerable groups with lenacapavir, a twice-yearly injectable HIV prevention drug, to improve adherence and reduce new infections, officials said.
8 Articles
8 Articles
Zimbabwe launches groundbreaking HIV prevention drug Lenacapavir
Zimbabwe has become one of the first countries globally to launch a national program for lenacapavir, a twice-yearly injectable HIV prevention drug, marking a major milestone in the country's fight to end AIDS as a public health threat.
Zimbabwe rolls out new HIV prevention drug lenacapavir
Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first globally to roll it out as the southern African nation seeks to curb new infections.
Zimbabwe Situation
The ZimbabweanOver 270k Zimbabweans to benefit from new HIV drug
Source: Over 270k Zimbabweans to benefit from new HIV drug – CITEZW The United States has launched lenacapavir (LEN), the new long-acting HIV prevention drug, in Zimbabwe, with plans to support 271,000 people over the next three years and prevent more than 9,000 new infections. Speaking at the national launch on Wednesday, United States Deputy Chief of Mission, Phillip Nervig, said the rollout marks a decisive moment in decades of U.S.–Zimbabwe…
Zimbabwe is continuing to consolidate its response to HIV. Health authorities have initiated the administration of lenacapavir, a long-acting injectable drug for prevention. With this deployment, the country of Southern Africa joins the still small group of states that are experimenting with this therapeutic innovation to further reduce new infections.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
